CIK 0000868278 · Non-accelerated filer<br>Smaller reporting company
ProPhase Labs, Inc.
Sign in to watch- Ticker
- PRPH
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 232577138
- Phone
- (215) 345-0919
- Business address
- 711 STEWART AVE, SUITE 200, GARDEN CITY, NEW YORK, NY, 11530
- Former names
- QUIGLEY CORP
- 4 Open-market buy Director bought 8,500 shares at $2.05 ($17,425)
- 4 Grant or award Director acquired 3,571 shares (grant or award)
- 4 Grant or award Director acquired 3,583 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 3,737 shares (grant or award)
- 4 Grant or award Director acquired 3,737 shares (grant or award)
- 4 Grant or award Director acquired 3,737 shares (grant or award)
- 4 Grant or award Director acquired 3,737 shares (grant or award)
- 4 Option exercise CEO & CHAIRMAN acquired 250,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3/A Insider 3/A
- 4 Open-market sale CEO & CHAIRMAN sold 424,789 shares at $2.30 ($977,015)
- 4 Option exercise CEO & CHAIRMAN acquired 600,000 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 1,695,305 shares at $2.30 ($3,899,202)
- 4 Open-market sale Director sold 4,379 shares at $2.30 ($10,072)
- 4 Open-market sale Chief Financial Officer sold 358,621 shares at $2.30 ($824,828)
- 4 Open-market sale CEO & CHAIRMAN sold 364,950 shares at $2.30 ($839,385)
- 4 Option exercise Chief Financial Officer acquired 360,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
Page 4 of 11 · 215 filings